Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 47 | 2025 | 5097 | 4.380 |
Why?
|
| Telemedicine | 5 | 2024 | 25 | 2.160 |
Why?
|
| Anti-HIV Agents | 14 | 2025 | 1324 | 2.060 |
Why?
|
| Humans | 67 | 2025 | 14537 | 1.800 |
Why?
|
| South Africa | 53 | 2025 | 7596 | 1.710 |
Why?
|
| Sexual Partners | 8 | 2025 | 215 | 1.660 |
Why?
|
| Cell Phone | 7 | 2021 | 34 | 1.650 |
Why?
|
| Female | 43 | 2025 | 9103 | 1.310 |
Why?
|
| Artificial Intelligence | 3 | 2024 | 10 | 1.290 |
Why?
|
| Rural Population | 10 | 2024 | 654 | 1.250 |
Why?
|
| Child Development | 3 | 2019 | 93 | 1.220 |
Why?
|
| Counseling | 7 | 2025 | 143 | 1.170 |
Why?
|
| Male | 34 | 2025 | 6754 | 1.160 |
Why?
|
| Adult | 34 | 2025 | 5913 | 1.160 |
Why?
|
| Depression | 3 | 2024 | 121 | 1.110 |
Why?
|
| Young Adult | 23 | 2024 | 2498 | 1.110 |
Why?
|
| Mothers | 5 | 2024 | 195 | 1.050 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 2023 | 187 | 1.040 |
Why?
|
| Mental Health Services | 2 | 2023 | 10 | 1.040 |
Why?
|
| Research Design | 3 | 2019 | 124 | 1.020 |
Why?
|
| Anti-Retroviral Agents | 3 | 2023 | 551 | 0.910 |
Why?
|
| Privacy | 2 | 2023 | 4 | 0.890 |
Why?
|
| Mass Screening | 9 | 2024 | 245 | 0.880 |
Why?
|
| Social Media | 2 | 2020 | 7 | 0.870 |
Why?
|
| Diabetes, Gestational | 1 | 2024 | 38 | 0.860 |
Why?
|
| Adolescent | 18 | 2024 | 2985 | 0.830 |
Why?
|
| Health Services Accessibility | 3 | 2021 | 280 | 0.790 |
Why?
|
| Tuberculosis | 3 | 2024 | 543 | 0.770 |
Why?
|
| Data Collection | 3 | 2019 | 86 | 0.750 |
Why?
|
| Surveys and Questionnaires | 7 | 2024 | 563 | 0.750 |
Why?
|
| Point-of-Care Systems | 4 | 2022 | 91 | 0.720 |
Why?
|
| Mental Health | 2 | 2019 | 91 | 0.720 |
Why?
|
| Pre-Exposure Prophylaxis | 1 | 2024 | 196 | 0.710 |
Why?
|
| Epidemiological Monitoring | 1 | 2020 | 45 | 0.690 |
Why?
|
| Patient Compliance | 4 | 2023 | 120 | 0.690 |
Why?
|
| Middle Aged | 15 | 2025 | 3601 | 0.680 |
Why?
|
| Technology | 1 | 2019 | 4 | 0.670 |
Why?
|
| Informed Consent | 1 | 2019 | 8 | 0.670 |
Why?
|
| Attitude | 1 | 2019 | 12 | 0.660 |
Why?
|
| Confidentiality | 1 | 2019 | 13 | 0.660 |
Why?
|
| Noncommunicable Diseases | 2 | 2018 | 77 | 0.660 |
Why?
|
| Alcohol Drinking | 2 | 2017 | 55 | 0.650 |
Why?
|
| Executive Function | 1 | 2019 | 23 | 0.640 |
Why?
|
| House Calls | 1 | 2019 | 9 | 0.630 |
Why?
|
| Interdisciplinary Research | 1 | 2017 | 2 | 0.580 |
Why?
|
| Depressive Disorder, Major | 1 | 2017 | 20 | 0.570 |
Why?
|
| Quality of Life | 1 | 2019 | 177 | 0.570 |
Why?
|
| Feasibility Studies | 5 | 2022 | 101 | 0.560 |
Why?
|
| Child, Preschool | 6 | 2022 | 1748 | 0.550 |
Why?
|
| Perception | 1 | 2017 | 42 | 0.550 |
Why?
|
| Developmental Disabilities | 1 | 2017 | 22 | 0.540 |
Why?
|
| Interviews as Topic | 3 | 2024 | 203 | 0.530 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2017 | 59 | 0.530 |
Why?
|
| Focus Groups | 5 | 2024 | 196 | 0.510 |
Why?
|
| Qualitative Research | 6 | 2024 | 321 | 0.480 |
Why?
|
| Developing Countries | 3 | 2023 | 400 | 0.440 |
Why?
|
| Delivery of Health Care | 5 | 2023 | 239 | 0.430 |
Why?
|
| Information Services | 1 | 2013 | 4 | 0.430 |
Why?
|
| Maternal Welfare | 1 | 2013 | 9 | 0.430 |
Why?
|
| Motivation | 3 | 2024 | 59 | 0.420 |
Why?
|
| Cohort Studies | 5 | 2024 | 967 | 0.420 |
Why?
|
| Infant | 9 | 2024 | 2244 | 0.420 |
Why?
|
| Community Health Services | 5 | 2024 | 58 | 0.420 |
Why?
|
| Pilot Projects | 5 | 2025 | 179 | 0.420 |
Why?
|
| Behavior Therapy | 2 | 2022 | 11 | 0.410 |
Why?
|
| Mentors | 4 | 2014 | 16 | 0.410 |
Why?
|
| Viral Load | 4 | 2024 | 819 | 0.410 |
Why?
|
| Child Health | 2 | 2023 | 77 | 0.400 |
Why?
|
| Efficiency, Organizational | 1 | 2012 | 5 | 0.400 |
Why?
|
| Global Health | 3 | 2021 | 193 | 0.390 |
Why?
|
| Pregnancy Complications, Infectious | 5 | 2014 | 529 | 0.360 |
Why?
|
| Pregnancy | 8 | 2024 | 1862 | 0.360 |
Why?
|
| Blood Glucose | 2 | 2024 | 107 | 0.360 |
Why?
|
| Cross-Sectional Studies | 6 | 2024 | 1422 | 0.360 |
Why?
|
| Public Health | 2 | 2022 | 124 | 0.350 |
Why?
|
| HIV | 2 | 2024 | 380 | 0.350 |
Why?
|
| Community Health Workers | 2 | 2023 | 66 | 0.320 |
Why?
|
| Child | 7 | 2023 | 2242 | 0.310 |
Why?
|
| Maternal Health Services | 3 | 2014 | 52 | 0.300 |
Why?
|
| Goals | 2 | 2024 | 7 | 0.280 |
Why?
|
| CD4 Lymphocyte Count | 4 | 2022 | 656 | 0.270 |
Why?
|
| Adiposity | 2 | 2018 | 96 | 0.270 |
Why?
|
| Medication Adherence | 2 | 2025 | 151 | 0.270 |
Why?
|
| Exercise | 2 | 2020 | 205 | 0.260 |
Why?
|
| Aged | 3 | 2024 | 1740 | 0.250 |
Why?
|
| Ambulatory Care Facilities | 2 | 2024 | 125 | 0.250 |
Why?
|
| Social Support | 2 | 2024 | 77 | 0.250 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2024 | 256 | 0.240 |
Why?
|
| Nepal | 1 | 2024 | 6 | 0.230 |
Why?
|
| Proof of Concept Study | 1 | 2024 | 13 | 0.230 |
Why?
|
| Dried Blood Spot Testing | 1 | 2024 | 24 | 0.230 |
Why?
|
| Reference Standards | 1 | 2024 | 29 | 0.230 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2024 | 4 | 0.230 |
Why?
|
| Cholesterol | 1 | 2024 | 38 | 0.220 |
Why?
|
| Bayes Theorem | 1 | 2024 | 81 | 0.220 |
Why?
|
| Self Report | 1 | 2024 | 114 | 0.220 |
Why?
|
| Motivational Interviewing | 1 | 2024 | 10 | 0.220 |
Why?
|
| Prevalence | 5 | 2024 | 1192 | 0.220 |
Why?
|
| Radiographic Image Enhancement | 1 | 2023 | 2 | 0.220 |
Why?
|
| Social Stigma | 1 | 2024 | 80 | 0.220 |
Why?
|
| Intelligence | 1 | 2023 | 6 | 0.220 |
Why?
|
| Language | 1 | 2023 | 14 | 0.210 |
Why?
|
| Family Characteristics | 2 | 2024 | 135 | 0.210 |
Why?
|
| Epidemics | 1 | 2023 | 65 | 0.210 |
Why?
|
| Social Sciences | 1 | 2022 | 1 | 0.210 |
Why?
|
| Biomarkers | 1 | 2024 | 327 | 0.200 |
Why?
|
| Primary Health Care | 1 | 2024 | 240 | 0.200 |
Why?
|
| Socioeconomic Factors | 3 | 2019 | 411 | 0.190 |
Why?
|
| Urban Population | 3 | 2018 | 257 | 0.180 |
Why?
|
| Psychomotor Performance | 2 | 2017 | 12 | 0.170 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2014 | 472 | 0.170 |
Why?
|
| Movement | 1 | 2020 | 5 | 0.170 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 42 | 0.170 |
Why?
|
| Videotape Recording | 1 | 2019 | 2 | 0.170 |
Why?
|
| Zambia | 2 | 2017 | 115 | 0.170 |
Why?
|
| Comprehension | 1 | 2019 | 5 | 0.170 |
Why?
|
| Wearable Electronic Devices | 1 | 2019 | 4 | 0.170 |
Why?
|
| Ethics, Research | 1 | 2019 | 6 | 0.170 |
Why?
|
| Mother-Child Relations | 1 | 2019 | 20 | 0.160 |
Why?
|
| Family | 1 | 2019 | 35 | 0.160 |
Why?
|
| Health Care Surveys | 1 | 2019 | 30 | 0.160 |
Why?
|
| Uganda | 4 | 2021 | 197 | 0.150 |
Why?
|
| Home Care Services | 1 | 2018 | 15 | 0.150 |
Why?
|
| Costs and Cost Analysis | 1 | 2018 | 42 | 0.150 |
Why?
|
| Menarche | 1 | 2018 | 13 | 0.150 |
Why?
|
| AIDS Serodiagnosis | 1 | 2018 | 44 | 0.150 |
Why?
|
| Infant, Newborn | 5 | 2020 | 1479 | 0.150 |
Why?
|
| Leg | 1 | 2018 | 21 | 0.150 |
Why?
|
| Peer Group | 3 | 2014 | 14 | 0.150 |
Why?
|
| Medication Therapy Management | 1 | 2017 | 5 | 0.150 |
Why?
|
| Anthropometry | 1 | 2018 | 102 | 0.140 |
Why?
|
| Hyperglycemia | 1 | 2017 | 15 | 0.140 |
Why?
|
| Models, Theoretical | 1 | 2017 | 80 | 0.140 |
Why?
|
| Government Employees | 1 | 2017 | 3 | 0.140 |
Why?
|
| Social Class | 1 | 2017 | 73 | 0.140 |
Why?
|
| Research | 1 | 2017 | 65 | 0.140 |
Why?
|
| HIV-1 | 1 | 2024 | 1260 | 0.130 |
Why?
|
| Intimate Partner Violence | 1 | 2016 | 55 | 0.130 |
Why?
|
| Risk Factors | 2 | 2017 | 1475 | 0.120 |
Why?
|
| Circumcision, Male | 1 | 2016 | 99 | 0.120 |
Why?
|
| Child Abuse, Sexual | 1 | 2014 | 4 | 0.120 |
Why?
|
| Community Networks | 1 | 2014 | 13 | 0.110 |
Why?
|
| Social Networking | 2 | 2024 | 8 | 0.110 |
Why?
|
| Obesity | 1 | 2017 | 367 | 0.110 |
Why?
|
| Health Behavior | 2 | 2014 | 79 | 0.110 |
Why?
|
| User-Computer Interface | 1 | 2013 | 6 | 0.110 |
Why?
|
| Analysis of Variance | 1 | 2013 | 64 | 0.110 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2016 | 472 | 0.110 |
Why?
|
| Lesotho | 2 | 2023 | 6 | 0.100 |
Why?
|
| Hypertension | 1 | 2017 | 419 | 0.100 |
Why?
|
| Treatment Outcome | 4 | 2020 | 889 | 0.100 |
Why?
|
| Sexual Behavior | 1 | 2014 | 320 | 0.100 |
Why?
|
| Efficiency | 1 | 2012 | 3 | 0.100 |
Why?
|
| Electronic Health Records | 1 | 2012 | 10 | 0.100 |
Why?
|
| Benchmarking | 1 | 2012 | 10 | 0.100 |
Why?
|
| Quality of Health Care | 1 | 2012 | 62 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2022 | 244 | 0.090 |
Why?
|
| Group Processes | 1 | 2011 | 3 | 0.090 |
Why?
|
| Pandemics | 2 | 2023 | 296 | 0.080 |
Why?
|
| Time Factors | 3 | 2020 | 507 | 0.080 |
Why?
|
| Postnatal Care | 3 | 2014 | 13 | 0.080 |
Why?
|
| Africa | 2 | 2023 | 376 | 0.080 |
Why?
|
| Waist Circumference | 2 | 2018 | 60 | 0.070 |
Why?
|
| Prenatal Care | 3 | 2014 | 147 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2014 | 262 | 0.070 |
Why?
|
| National Institute of Mental Health (U.S.) | 2 | 2014 | 3 | 0.060 |
Why?
|
| Substance-Related Disorders | 1 | 2024 | 51 | 0.060 |
Why?
|
| Organizational Culture | 1 | 2024 | 7 | 0.060 |
Why?
|
| Bias | 1 | 2024 | 15 | 0.060 |
Why?
|
| United States | 2 | 2014 | 132 | 0.060 |
Why?
|
| Leadership | 1 | 2024 | 23 | 0.060 |
Why?
|
| Blood Alcohol Content | 1 | 2024 | 1 | 0.060 |
Why?
|
| Trust | 1 | 2024 | 9 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2024 | 188 | 0.060 |
Why?
|
| Interpersonal Relations | 1 | 2024 | 43 | 0.050 |
Why?
|
| Specimen Handling | 1 | 2024 | 105 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 217 | 0.050 |
Why?
|
| Radiography | 1 | 2023 | 80 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2024 | 385 | 0.050 |
Why?
|
| Single-Blind Method | 1 | 2022 | 17 | 0.050 |
Why?
|
| Men | 1 | 2023 | 15 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2024 | 231 | 0.050 |
Why?
|
| Health Services | 1 | 2023 | 51 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2014 | 65 | 0.050 |
Why?
|
| Risk Reduction Behavior | 2 | 2014 | 39 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2024 | 284 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 22 | 0.050 |
Why?
|
| Adaptation, Psychological | 2 | 2012 | 26 | 0.050 |
Why?
|
| Computers, Handheld | 1 | 2021 | 2 | 0.050 |
Why?
|
| Remote Consultation | 1 | 2001 | 2 | 0.050 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2001 | 3 | 0.050 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2024 | 324 | 0.050 |
Why?
|
| Men's Health | 1 | 2020 | 3 | 0.040 |
Why?
|
| Reward | 1 | 2020 | 2 | 0.040 |
Why?
|
| Continuity of Patient Care | 1 | 2020 | 33 | 0.040 |
Why?
|
| Stakeholder Participation | 1 | 2020 | 9 | 0.040 |
Why?
|
| HIV Seroprevalence | 1 | 2018 | 15 | 0.040 |
Why?
|
| Body Height | 1 | 2018 | 52 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2018 | 107 | 0.040 |
Why?
|
| Isoniazid | 1 | 2018 | 110 | 0.030 |
Why?
|
| Problem Solving | 1 | 2016 | 3 | 0.030 |
Why?
|
| Age Factors | 1 | 2018 | 370 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 1160 | 0.030 |
Why?
|
| Overweight | 1 | 2017 | 87 | 0.030 |
Why?
|
| Psychometrics | 1 | 2016 | 22 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2016 | 43 | 0.030 |
Why?
|
| Educational Status | 1 | 2016 | 68 | 0.030 |
Why?
|
| Communication | 1 | 2016 | 57 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2016 | 57 | 0.030 |
Why?
|
| Caregivers | 1 | 2016 | 76 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2017 | 321 | 0.030 |
Why?
|
| Aging | 1 | 2016 | 109 | 0.030 |
Why?
|
| Random Allocation | 1 | 2014 | 23 | 0.030 |
Why?
|
| Directive Counseling | 1 | 2014 | 15 | 0.030 |
Why?
|
| Tanzania | 1 | 2014 | 88 | 0.030 |
Why?
|
| Zimbabwe | 1 | 2014 | 120 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2014 | 89 | 0.030 |
Why?
|
| Interview, Psychological | 1 | 2012 | 6 | 0.030 |
Why?
|
| Alcoholic Intoxication | 1 | 2011 | 3 | 0.020 |
Why?
|
| Marital Status | 1 | 2011 | 11 | 0.020 |
Why?
|
| Risk-Taking | 1 | 2011 | 121 | 0.020 |
Why?
|
| Telecommunications | 1 | 2001 | 1 | 0.010 |
Why?
|
| Ophthalmology | 1 | 2001 | 3 | 0.010 |
Why?
|
| Hospitals, Special | 1 | 2001 | 4 | 0.010 |
Why?
|
| Interinstitutional Relations | 1 | 2001 | 7 | 0.010 |
Why?
|
| Hospitals, District | 1 | 2001 | 5 | 0.010 |
Why?
|